| Perioperative myeloid cell remodeling shapes CAR-T cell efficacy in glioblastoma | Nature communications |  | | 2026 | 1 | 0 |
|
| Targeting the extracellular matrix with Tenascin-C-specific CAR T cells extends survival in preclinical models of glioblastoma | Journal for immunotherapy of cancer | | | 2025 | 1 | 1 |
|
| Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma | OncoImmunology | | | 2020 | 463 | 346 |
|
| Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients | Frontiers in Oncology | | | 2020 | 357 | 197 |
|
| Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients | Neuro-Oncology | | | 2019 | 857 | 860 |
|
| Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma | OncoImmunology | | | 2018 | 671 | 438 |
|
